2028 年制药灌装和包装外包市场规模、份额、增长和趋势分析及预测

  • Report Code : TIPRE00017482
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 158
Buy Now

 

药品灌装和封装外包市场规模预计将从 2021 年的 26.5704 亿美元增至 2028 年的 40.1051 亿美元;预计 2021 年至 2028 年的复合年增长率为 6.1%。

制药和生物制药行业为填补/完成缺口而不断增长的需求预计将推动市场增长。根据美国食品药品监督管理局 (FDA) 药品评估和研究中心 (CDER) 的数据,2020 年生物制剂占新分子实体 (NME) 批准的 20% 至 29%。2019 年,小分子占所有 NME 批准的 79%,占 FDA 批准的 48 个 NME 中的 38 个,生物制剂占批准的 48 个 NME 中的 10 个,或占所有 NME 批准的 21%。2018 年,小分子占 NME 批准的 71%,生物制剂占 NME 批准的 29%。内部产能不足的公司有时缺乏生产新产品的能力。这一因素支持了市场的增长。冻干、预充式注射器和药筒灌装或新型疗法等专业能力需要独特的制造技术,生物技术公司发现从合同制造组织外包这些技术是有益的,因为它们具有成本效益。拥有内部无菌灌装和封口能力的公司平均将 39% 的灌装和封口需求外包。

2021-2028 年,北美很可能继续在医药灌装和精加工外包市场占据主导地位。美国在北美市场占有最大份额,预计在预测期内将继续保持这一趋势。机器人等自动化进步一直是美国灌装/精加工业务取得进展的领域之一。这主要在很大程度上降低了污染风险,从而有助于区域增长。减少人际互动的供应链整体整合正在推动医药灌装和精加工外包市场的增长。例如,ABL 于 2017 年在其灌装/精加工业务中采用了自动化。该公司在马里兰州罗克维尔的 GMP 生物制造工厂完成了无菌灌装/精加工业务的扩建。该公司安装了一套全自动小瓶灌装系统。这些因素预计将促进整个医药灌装和精加工外包市场的增长。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

制药灌装和封装外包市场:

Pharmaceutical Fill and Finish Outsourcing Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

 

市场洞察

 

生物制品需求激增

生物药物管道的不断增加以及对此类治疗干预措施的日益偏好预计将在预测期内推动对药品灌装和包装外包的需求。大约 60% 的灌装/包装服务涉及抗 COVID-19 疫苗的临床和商业规模包装。设施扩建是生物制药公司在疫情期间考虑的关键因素之一。生物制药公司正面临上述变化和预算限制等问题。需要外包来克服这些问题并满足生物制品的需求。预计未来七年,从合同制造组织外包生物制药产品将推动药品灌装和包装外包行业的发展。大约 90% 的已安装灌装/包装产能属于具有商业规模生产能力的市场参与者。超过 85% 的可用灌装和包装产能属于大型公司。

 

基于成品状况的洞察

根据成品状态,药品灌装和完成外包市场细分为固体、半固体和液体。液体部分在 2021 年占据了最大份额,预计在预测期内将继续保持类似的趋势。塑料注射器行业对预充式注射器和小瓶的需求不断增长,预计将推动对药品灌装和完成外包的需求。小瓶在冻干中的应用需求正在推动灌装和完成服务市场的增长。此外,全球生物制剂制造业新进入者数量的增加导致外包活动激增。预计这一因素将有助于全球药品灌装和完成外包市场。

根据内容,药品灌装和包装外包市场分为从微生物中分离的有机物质、从动物中分离的有机物质和无机物质。从微生物中分离的有机物质部分占有相当大的市场份额,预计在预测期内将继续保持类似的趋势。药品灌装和包装外包的进步使得成功实施了降低供应链中污染风险的措施。这种端到端的集成成功地促进了对从微生物中分离的有机物质的需求,从而促进了对药品灌装和包装外包的需求。

在药品灌装和封装外包市场运营的公司采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。

 

 

制药灌装和完成外包市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响制药灌装和包装外包市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的制药灌装和包装外包市场细分和地理位置。

Pharmaceutical Fill and Finish Outsourcing Market
  • 获取药品灌装和完成外包市场的区域特定数据

制药灌装和完成外包市场报告范围

报告属性细节
2021 年市场规模26.6亿美元
2028 年市场规模40.1亿美元
全球复合年增长率(2021 - 2028)6.1%
史料2019-2020
预测期2022-2028
涵盖的领域按成品状态
  • 固体
  • 半固体
  • 液体
按内容
  • 从动物源中分离的有机物质
  • 从微生物中分离的有机物质
  • 无机物质
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 雅培
  • 梯瓦制药工业有限公司
  • 雷迪博士实验室
  • 太阳制药工业有限公司
  • 皮拉马尔企业有限公司
  • 迈百瑞国际有限公司
  • 沃克哈特
  • Cytovance 生物制剂
  • 赛默飞世尔科技公司(Patheon NV)

市场参与者密度:了解其对商业动态的影响

制药灌装和包装外包市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在制药灌装和封装外包市场运营的主要公司有:

  1. 雅培
  2. 梯瓦制药工业有限公司
  3. 雷迪博士实验室
  4. 太阳制药工业有限公司
  5. 皮拉马尔企业有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Pharmaceutical Fill and Finish Outsourcing Market

 

  • 获取制药灌装和完成外包市场顶级关键参与者概览

 

 

药品灌装和封装外包市场 

全球医药灌装和封装外包市场根据成品状态和含量进行细分。根据成品状态,市场分为液体、固体和半固体。根据含量,市场分为从微生物中分离的有机物质、从动物中分离的有机物质和无机物质。根据地区,全球医药灌装和封装外包市场分为北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美市场分为美国、加拿大和墨西哥。欧洲市场分为法国、德国、意大利、西班牙、英国和欧洲其他地区。亚太地区分为中国、日本、韩国、印度、澳大利亚和亚太其他地区。中东和非洲分为南非、沙特阿拉伯、阿联酋和中东和非洲其他地区。南美洲和中美洲分为巴西、阿根廷和南美洲和中美洲其他地区。

在市场上运营的公司包括雅培 (Abbott)、梯瓦 (TEVA) PHARMACEUTICAL INDUSTRIES LTD、雷迪博士实验室 (Dr. Reddy's Laboratories)、太阳制药工业有限公司 (Sun Pharmaceutical Industries Ltd)、Piramal Enterprises Ltd.、MabPlex International Ltd、WOCKHARDT、Cytovance Biologics、赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.) (Patheon NV)、勃林格殷格翰国际有限公司 (Boehringer Ingelheim International GmbH) 等。  

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of the pharmaceutical fill and finish outsourcing market?

Global pharmaceutical fill and finish outsourcing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the pharmaceutical fill and finish outsourcing market during 2021–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. Automation advancements such as robotics have been one of the areas of progress for the US fill/finish operations. This primarily reduces the contamination risk to a great extent, thus aiding the regional growth. The overall integration of the supply chain that reduces human interactions is driving the pharmaceutical fill and finish outsourcing market growth.

Which application segment held the largest revenue (US$ Mn) in the pharmaceutical fill and finish outsourcing market?

The liquid segment accounted for the largest share in 2021 and is expected to continue during the forecast period.

Who are the key players in the pharmaceutical fill and finish outsourcing market?

Companies operating in the market are Abbott, TEVA PHARMACEUTICAL INDUSTRIES LTD, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Piramal Enterprises Ltd., MabPlex International Ltd, WOCKHARDT, Cytovance Biologics, Thermo Fisher Scientific Inc. (Patheon N.V), Boehringer Ingelheim International GmbH amongst others.

What is meant by the pharmaceutical fill and finish outsourcing market?

Biopharmaceutical companies and pharmaceutical companies outsource a portion of the products from the contract outsourcing companies to meet the unmet demand of the companies. This process is termed as the pharmaceutical fill and finish outsourcing.

What are the driving factors for the pharmaceutical fill and finish outsourcing market across the globe?

Rising investment in biopharmaceutical sectors and growing demand for biologics is expected to drive the market

Which segment led the pharmaceutical fill and finish outsourcing market?

Based on content, organic substances isolated from microorganisms took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue a similar trend over the forecast period.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Pharmaceutical Fill and Finish Outsourcing Market

  1. Abbott
  2. Teva Pharmaceutical Industries Ltd
  3. Dr. Reddy's Laboratories
  4. Sun Pharmaceutical Industries Ltd
  5. Piramal Enterprises Ltd
  6. MabPlex International Ltd
  7. Wockhardt
  8. Cytovance Biologics
  9. Thermo Fisher Scientific Inc. (Patheon N.V.)
  10. Boehringer Ingelheim International GmbH

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.